STEMI treatment in remote areas – challenges of the only interventional angioplasty center located in an archipelago. (14th October 2021)

• Record Type: Journal Article
• Authors: Barradas Da Silva, M; Duarte, F; Oliveira, L; Serena, C; Fontes, A; Monteiro, A; Machado, C; Dourado, R; Santos, E; Pelicano, N; Pacheco, M; Tavares, A; Martins, D
• Is Part Of: European heart journal. Volume 42(2021)Supplement 1
• Publication Date: 2021-10-14
• Subjects: Revascularisation; Cardiology -- Periodicals; Heart -- Diseases -- Periodicals; 616.12005
• DOI: 10.1093/eurheartj/ehab724.1443
• Languages: English
• ISSNs: 0195-668X

Abstract

Abstract: Background: In remote islands lack of specialized medical facilities, long distance transfer and emergency medical system organization remains a challenge and fibrinolysis is necessary to achieve revascularization in optimal timing in ST-elevation myocardial infarction (STEMI) patients. Our angioplasty center is the only one located in an archipelago composed of nine islands, six of which do not have hospital facilities and only have small family health care units. Purpose: To evaluate the reality and outcomes of our interventional angioplasty center and compare cardiovascular outcomes between STEMI patients from the main island and remote islands. Methods: We retrospectively evaluated 103 patients with STEMI admitted to our center between 2018 and 2019. Patients from the main island where the center is located underwent primary percutaneous coronary intervention (PCI) (group 1, n=55) and patients from remote islands underwent fibrinolytic therapy followed by transference to our center with facilitated or rescue PCI (group 2, n=48). A subanalysis of the far remote islands without hospital facilities was also performed. Primary outcome was defined as cardiovascular death or re-infarction at two years and secondary outcome as intrahospital haemorrhagic complications. Results: Mean age was 58, 15±12, 6 years, 85, 4% were males and follow up period was 30, 30±6, 46 months. Seventy-eight patients (75, 7%) had history of smoking, 45 (43, 7%) dyslipidemia, 20 (19, 4%) previous acute coronary syndrome, 18 (17, 5%) diabetes and 17 (15, 5%) were obese. Troponin I peak was 117, 42±129, 06 ug/L and 14 (13, 6%) were in Killip Class III/IV. Infarct-related artery was the left anterior descending artery in 45 (45, 5%) and multivessel disease was present in 38 (38, 0%). In group 1 reperfusion after PCI was obtained in 91, 5%. In group 2, 73, 5% met criteria for reperfusion after fibrinolysis and 23, 6% after rescue PCI. Mean time from fibrinolysis to PCI was 558±349 minutes. Rates of successful revascularization did not differ between groups, as well as complete patency of the culprit-vessel defined as thrombolysis in myocardial infarction (TIMI) flow 3 (91, 5% vs. 97, 2% and 90, 0% vs. 93, 0% respectively for group 1 and 2). Cardiovascular death at two years occurred in 4 (3, 9%) patients and re-infarction in 11 (10, 7%) and were similar between groups (3 (5, 5%) vs. 1 (2, 1%) and 8 (14, 5%) vs. 3 (6, 3%) respectively) as well as haemorrhagic complications (1 (1, 8%) vs. 5 (10, 4%) respectively). Nineteen (18, 4%) patients were from far remote islands without hospital facilities and when comparing these patients with the others there was also no difference in primary outcome. Conclusion: Even in remote islands, an organized STEMI network with attempted fibrinolytic treatment and coordinated transference of patients for facilitated or rescue PCI can provide successful revascularization with cardiovascular outcomes similar to those submitted to primary PCI. FUNDunding Acknowledgement: Type of funding sources: None.